AMERIPRISE FINANCIAL INC - TRANSPHORM INC ownership

TRANSPHORM INC's ticker is TGAN and the CUSIP is 89386L100. A total of 40 filers reported holding TRANSPHORM INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of TRANSPHORM INC
ValueSharesWeighting
Q3 2023$9,864,191
-28.6%
4,443,329
+9.3%
0.00%
-25.0%
Q2 2023$13,816,816
-11.9%
4,063,769
+3.4%
0.00%
-20.0%
Q1 2023$15,676,901
-24.3%
3,929,048
+3.2%
0.01%
-28.6%
Q4 2022$20,702,000
+8.1%
3,805,548
-0.0%
0.01%0.0%
Q3 2022$19,142,000
+33.2%
3,805,595
+0.9%
0.01%
+40.0%
Q2 2022$14,369,000
-43.6%
3,771,267
+4.7%
0.01%
-37.5%
Q1 2022$25,470,0003,602,4810.01%
Other shareholders
TRANSPHORM INC shareholders Q3 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 3,609,346$14,401,2915.31%
Kohlberg Kravis Roberts & Co. L.P. 22,675,980$90,477,1602.72%
Worth Venture Partners, LLC 884,802$3,530,3601.72%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 253,084$1,009,8051.18%
Black Maple Capital Management LP 43,161$172,2120.16%
Polar Asset Management Partners Inc. 709,700$2,831,7030.04%
Soros Fund Management 639,820$2,552,8820.04%
AMERIPRISE FINANCIAL INC 3,929,048$15,676,9010.01%
Stratos Wealth Partners, LTD. 25,640$102,3040.00%
FMR LLC 1,584$6,3200.00%
View complete list of TRANSPHORM INC shareholders